Kurma Partners is a private equity general partner firm headquartered in Paris, France.
Vivet Therapeutics, a French emerging biotechnology company, has raised €37.5m in a Series A from Novartis Venture Fund and others.
ImCheck Therapeutics, a France-based biotech company, raised €20m in Series A from Boehringer Ingelheim Venture Fund and others.
Damae Medical, a France-based medtech company, raised €2m from Kurma Partners, Idinvest Partners, News Invest and others.
Read more news concerning Kurma Partners
A sampling of Kurma Partners portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?